Premium Nahrungsergänzungsmittel | artgerecht

Intestinal Barrier Markers – Definition & Diagnostics

Intestinal barrier markers are laboratory values that assess the integrity of the gut lining and are used when increased intestinal permeability, or leaky gut, is suspected.

Regular tips about health Regular tips about health

Things worth knowing about "Intestinal barrier markers"

Intestinal barrier markers are laboratory values that assess the integrity of the gut lining and are used when increased intestinal permeability, or leaky gut, is suspected.

What are intestinal barrier markers?

Intestinal barrier markers are specific laboratory parameters used to evaluate the function and integrity of the intestinal mucosa – the lining of the gut. The gut lining acts as a selectively permeable protective barrier between the intestinal lumen and the bloodstream. When this barrier is compromised, bacteria, toxins, and undigested food particles can enter the circulation – a condition known as increased intestinal permeability or, colloquially, leaky gut.

Clinical relevance

A damaged intestinal barrier has been associated with a wide range of conditions, including:

Inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis)
Irritable bowel syndrome (IBS)
Food intolerances and allergies
Autoimmune diseases
Metabolic syndrome and obesity
Systemic inflammatory responses (sepsis)

By measuring intestinal barrier markers, clinicians can detect early signs of compromised barrier function and initiate targeted therapeutic measures.

Key intestinal barrier markers

Zonulin

Zonulin is a protein that regulates the opening of tight junctions – the sealing connections between intestinal epithelial cells. Elevated zonulin levels in blood or stool are considered an indicator of increased intestinal permeability. Raised levels are frequently found in patients with celiac disease, inflammatory bowel disease, and type 1 diabetes mellitus.

Alpha-1-antitrypsin (A1AT) in stool

Alpha-1-antitrypsin is a plasma protein that is not normally secreted into the gut in significant quantities. Elevated fecal A1AT indicates pathological protein loss through the gut mucosa, known as protein-losing enteropathy, and is a well-established marker of intestinal barrier damage.

Fatty acid-binding protein 2 (FABP2 / I-FABP)

Intestinal fatty acid-binding protein (I-FABP) is produced exclusively in enterocytes (intestinal epithelial cells). When these cells are injured or destroyed, I-FABP is released into the bloodstream. Elevated serum levels are a sensitive indicator of acute intestinal mucosal damage, such as in ischemia, sepsis, or severe inflammation.

Fecal calprotectin

Calprotectin is a protein found mainly in neutrophil granulocytes (immune cells). Elevated fecal calprotectin signals inflammation of the intestinal mucosa and is widely used to differentiate between organic bowel diseases (e.g., Crohn's disease) and functional disorders (e.g., IBS).

Lipopolysaccharide-binding protein (LBP)

LBP is an acute-phase protein that binds to lipopolysaccharides (LPS) – components of the cell wall of gram-negative bacteria. Elevated blood LBP levels may indicate increased translocation of bacterial components from the gut into the bloodstream, a process referred to as bacterial translocation.

Diagnosis and testing

Intestinal barrier markers are measured either in blood (serum) or in stool, depending on the specific marker. Analysis is performed in specialized laboratories using immunological methods such as ELISA. In addition, intestinal permeability can be assessed using functional tests such as the lactulose-mannitol test, in which both sugars are ingested orally and their urinary ratio is subsequently measured.

Treatment options for impaired intestinal barrier function

When increased intestinal permeability is identified, several therapeutic approaches may help restore barrier integrity:

Dietary changes: Reducing sugar, alcohol, and highly processed foods; gluten-free diet in celiac disease
Probiotics and prebiotics: Supporting a healthy gut microbiome
L-glutamine: An amino acid that serves as a key energy source for intestinal cells
Zinc: Contributes to stabilizing tight junctions
Treatment of the underlying condition: e.g., pharmacological therapy for Crohn's disease or ulcerative colitis
Stress reduction: Chronic stress can negatively affect the intestinal barrier

References

Fasano, A. (2012): Leaky gut and autoimmune diseases. Clinical Reviews in Allergy & Immunology, 42(1), 71–78. doi:10.1007/s12016-011-8291-x
Camilleri, M. (2019): Leaky gut: mechanisms, measurement and clinical implications in humans. Gut, 68(8), 1516–1526. doi:10.1136/gutjnl-2019-318427
Turner, J. R. (2009): Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology, 9(11), 799–809. doi:10.1038/nri2653

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category